← Open Payments lookup

DANIEL MEAD: Open Payments

NPI 1225593726 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,181 in 79 payments from 15 companies in 2025. Trend: 2023 $894 · 2024 $278 · 2025 $2,181

Food & beverage: $1,960Education: $221
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.14$403
Otsuka America Pharmaceutical, Inc.11$403
Neurocrine BioSciences, Inc.18$362
Lundbeck LLC8$233
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$212
Axsome Therapeutics, Inc.4$111
Alkermes, Inc.4$109
Corium, LLC3$94
Vanda Pharmaceuticals Inc.2$69
E.R. Squibb & Sons, L.L.C.3$66

Products named: REXULTI, INGREZZA, CAPLYTA, Auvelity, ARISTADA, Azstarys, UZEDY, AUSTEDO XR.

Industry payments across MI — which companies pay providers there.